In-depth risk guides
Plain-language guides examine ibogaine treatment deaths, reported risk factors, and the limits of what any individual account can establish. Start with the main risk overview for the central context behind this resource.
Independent information resource
Services
Guides, comparisons, and research summaries for people seeking plain language about ibogaine treatment deaths, serious risks, and uncertainty.
These are information services, not medical or clinical services. The aim is to make difficult safety questions easier to find, name, and consider.
What is available
Information built for careful reading.
The material is organized to help people distinguish documented concerns from assumptions, identify evidence limits, and keep safety questions visible rather than buried in promotional language.
Decision frameworks
Structured questions can help readers slow down around claims of safety, screening, monitoring, emergency readiness, and uncertainty. They are not a substitute for individualized medical advice or an assessment of personal risk.
Cost and claim comparisons
When treatment is discussed alongside cost, the financial picture should not crowd out safety concerns. The independent material at ibogaine treatment cost comparisons can be considered alongside questions about what claims are being made and what remains unknown.
Research summaries and glossary
Short summaries and definitions are designed to make technical language less opaque without overstating certainty. Our approach to evidence limits explains why careful sourcing, transparent uncertainty, and human dignity guide this work.
A focused reading path
Cardiac risk needs clear terms.
Ibogaine is associated with cardiac safety concerns, including changes in cardiac electrical activity. The U.S. Food and Drug Administration notes that drug-induced QT prolongation can be associated with torsades de pointes, a potentially life-threatening arrhythmia, in its FDA explanation of abnormal heart rhythms.
- Definitions that separate a reported event from a demonstrated cause.
- Focused context for discussions of screening and monitoring claims.
- A careful route into documented gaps and questions that remain unanswered.
Evidence limits stay visible
Information can clarify. It cannot clear a risk.
Ibogaine is a psychoactive substance derived from plants in the Apocynaceae family, and its history, pharmacology, and use are often discussed with more certainty than the evidence can support. The reference overview of ibogaine describes its origin and psychoactive properties, but a broad reference page is not an individual safety evaluation.
Still Threshold 12 provides material intended to help people read claims with more care: what is documented, what is reported, what may be missing, and which questions deserve direct answers. It does not decide whether ibogaine is safe for a particular person.
“The serious possibility of harm deserves plain language, not reassurance by default.”
Common questions
Use the material with its limits intact.
Short answers to questions that often arise when people are looking for information rather than care.
-
Are these medical or treatment services?
No. Still Threshold 12 is an independent information resource. It does not provide medical care, treatment plans, diagnosis, legal advice, or clinical referrals.
-
Why focus on deaths and cardiac risk?
The purpose is to make serious safety concerns easier to locate and understand. Ibogaine has documented cardiac safety concerns, and treatment-related deaths have been reported; the safety gaps and considerations page keeps that uncertainty in view.
-
Can an information guide determine whether treatment is safe?
No. A guide cannot assess an individual situation or replace qualified medical advice. It can help readers identify evidence limits and questions that may need careful consideration.
Safety first · Plain language
A calmer place to begin difficult questions.
Explore the resource’s risk-focused materials with the understanding that documented concerns, unknowns, and human stakes belong in the same conversation.
Contact the resource